期刊文献+

特发性炎性肌病进展 被引量:8

The advance of idiopathic inflammatory myopathy
下载PDF
导出
摘要 特发性炎性肌病(IIM)是一组具有不同临床表现和病理学特点的骨骼肌免疫性疾病,通常包括多发性肌炎(PM)、皮肌炎(DM)、免疫性坏死性肌病(NAM)、包涵体肌炎(IBM)、结缔组织病相关性免疫性坏死性肌病和罕见类型的炎性肌病。炎性肌病不同类型构成比随疾病研究的深入显著改变,其中95%曾诊断的多发性肌炎重新经病理学和免疫学评估而改变诊断。多发性肌炎除名称外可能已不复存在,更多可能是伴特殊抗体的炎性肌病、重叠性肌炎或结缔组织病相关性免疫性坏死性肌病,疾病谱的改变需临床医师重新认识不同炎性肌病的临床表现。
作者 袁云
出处 《中国现代神经疾病杂志》 CAS 2016年第10期647-650,共4页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 国家科技重大专项课题-重大新药创制(项目编号:2011ZX09307-001-07)Projects(No.2011ZX09307-001-07)~~
关键词 肌炎 综述 Myositis Review
  • 相关文献

参考文献33

  • 1Milisenda JC, Selva-O'Callaghan A, Grau JM. The diagnosis and classification of polymyositis. J Autoimmun, 2014, 48/49: 118-121. 被引量:1
  • 2Mamyrova G, Katz JD, Jones RV, Targoff IN, Lachenbruch PA, Jones OY, Miller FW, Rider LG; Childhood Myositis Heterogeneity Collaborative Study Group. Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy. Arthritis Care Res (Hoboken), 2013, 65:1969-1975. 被引量:1
  • 3Vilela VS, Prieto-Gonzdlez S, Milisenda JC, Selva-O Callaghan A, Grau JM. Polymyositis, a very uncommon isolated disease: clinical and histological re-evaluation after long-term follow-up. Rheumatol Int, 2015, 35:915-920. 被引量:1
  • 4Tansley SL, McHugh N J, Wedderburn LR. Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms? Arthritis Res Ther, 2013, 15:211. 被引量:1
  • 5Sunderkutter C, Nast A, Worm M, Dengler R, Dorner T, Ganter itl, Hohlfeld R, Melms A, Melzer N, Rosler K, Sehmidt J, Sinnreich M, Walter MC, Wanschitz J, Wiendl H. Guidelines on dermatamyositis- excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. J Dtsch Dermatol Ges, 2016, 14:321-338. 被引量:1
  • 6Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourn-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Sen6cal JL. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore), 2014, 93:318-332. 被引量:1
  • 7Sheik All S, Goddard AL, Luke JJ, Donahue H, Todd DJ, Werchniak A, Vleugels RA. Drug-associated dermatomyositis following ipilimumab therapy: a novel immune - mediated adverse event associated with eytotoxic T-lymphocyte antigen 4 blockade. JAMA Dermatol, 2015, 151:195-199. 被引量:1
  • 8Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neural, 2015, 72:996-1003. 被引量:1
  • 9Wang L, Liu L, Hao H, Gao F, Liu X, Wang Z, Zhang W, Lv H, Yuan Y. Myopathy with anti- signal recognition particle antibodies: clinical and histopathological features in Chinese patients. Neuromuscul Disord, 2014, 24:335-341. 被引量:1
  • 10Lundberg IE, Miller FW, Tjarnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med, 2016, 280:39-51. 被引量:1

二级参考文献16

  • 1Sathasivam S. Statin induced myotoxicity[ J]. Eur J Intern Med, 2012, 23(4) :317-324. 被引量:1
  • 2Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al. ACC/AHAZ NHLBI Clinical Advisory on the Use and Safety of Statins [ J ]. Circulation, 2002, 106 ( 8 ) : 1024-1028. 被引量:1
  • 3Mammen AL, Chung T, Christopher-Stine L, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmnne myopathy [J]. Arthritis Rheum, 2011, 63(3) :713-721. 被引量:1
  • 4Wemer JL, Christopher-Stine L, Ghazarian SR, et al. Antibody levels correlate with creatine kinase levels and strength in anti-3- hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy [ J]. Arthritis Rheum, 2012, 64 ( 12 ) : 4087 -4093. 被引量:1
  • 5Tomaszewski M, Stpiefi KM, Tomaszewska J, et al. Statin- induced myopathies [ J ]. Pharmacol Rep, 2011 , 63 (4) : 859- 866. 被引量:1
  • 6Allenbach Y, Benveniste O. Acquired necrutizing myopathies[ J]. Curr Opin Neurol, 2013, 26(5 ) :554-560. 被引量:1
  • 7Mohassel P, Mammen AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies [ J]. Muscle Nerve, 2013, 48 (4) :477-483. 被引量:1
  • 8Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis [ J ]. N Engl J Med, 2002, 346 ( 7 ) :539-540. 被引量:1
  • 9Padala S, Thompson PD. Statins as a possible cause of inflammatory and necrotizing myopathies [ J ]. Atherosclerosis, 2012, 222(1 ) :15-21. 被引量:1
  • 10Meriggioli MN, Barboi AC, Rowin J, et al. HMG-CoA reductase inhibitor myopathy: clinical, electrophysiological, and pathologic data in five patients[ J]. J Clin Neuromuscul Dis, 2001, 2 (3) : 129-134. 被引量:1

共引文献6

同被引文献26

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部